Overview

Hemodynamics During Induction of General Anesthesia With Medium or Low Remifentanil Doses.

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
0
Participant gender:
Female
Summary
In this trial the investigators want to examine if there is any difference in hemodynamic stability during induction when comparing two low and a medium remifentanil dose and keeping propofol induction dose at about 2.0 mg/kg.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Helse Fonna
Treatments:
Remifentanil
Criteria
Inclusion Criteria:

- Gynecological procedure

- Age 18-50 years

- General anesthesia planned

- Systolic blood pressure < 150 mmHg, HR < 100 beats/min

Exclusion Criteria:

- Pre-existing hypertension

- Diabetes

- Ischemic heart disease or cerebrovascular disease

- Heart valve disease

- Verified cardiac arrhythmia other than extrasystoles

- Verified anaemia with hemoglobin level below 9.0 gr/dl.

- Kidney or hepatic disease

- Hypersensitivity for propofol, soya, eggs or peanuts

- Pregnancy

- Poor health state

- Illicit substance use

- BMI <20 or >35 kg/m2